Annovis Bio, Inc.ANVSNYSE

Revenue (LTM)

Net Income (LTM)

$-29M

-17.3% YoY

Free Cash Flow

$-25.6B

Revenue CAGR (5Y)

—

—Marginsstable

FCF($25.6B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-15	-26↓75.5%	-45↓76.5%	-27↑40.7%	-30↓11.2%
Net Income	-14	-25↓74.8%	-56↓121.9%	-25↑56.2%	-29↓17.3%
EBITDA	-15	-26↓75.9%	-45↓76.5%	-27↑40.7%	-30↓11.2%
EPS Diluted	-1.90	-3.10↓63.2%	-6.23↓101.0%	-2009.77↓32159.6%	-1.40↑99.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	46	28↓37.9%	6↓79.7%	11↑83.4%	19,532↑185007.0%
Total Current Assets	46	36↓21.7%	10↓71.7%	14↑36.4%	19,532↑140161.8%
Total Assets	46	36↓21.7%	10↓71.7%	14↑36.4%	21,082↑151287.2%
Total Current Liabilities	2	8↑411.0%	4↓44.4%	4↓9.3%	3,635↑93571.4%
Total Liabilities	2	8↑411.0%	18↑133.3%	5↓74.3%	4,230↑91506.5%
Total Equity	44	28↓36.3%	-8↓127.4%	9↑220.1%	16,851↑180947.4%
Total Debt	0	0	0	0	0
Net Debt	-46	-28↑37.9%	-6↑79.7%	-11↓83.4%	-19,532↓185007.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-9	-17↓89.6%	-40↓130.9%	-21,895↓54681.3%	-25,620↓17.0%
Capital Expenditure	0	0	0	0	0
Free Cash Flow	-9	-17↓89.6%	-40↓130.9%	-21,895↓54681.3%	-25,620↓17.0%
Stock-Based Comp	5	9↑94.8%	5↓49.4%	3,837↑82796.1%	1,798↓53.1%
Net Change in Cash	38	-17↓146.0%	-23↓30.7%	4,797↑21305.0%	8,980↑87.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance